Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mari Iida

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Advanced Healthcare Materials|April 17, 2025
Dendrimer Conjugates with PD-L1-Binding Peptides Enhance In Vivo Antitumor Immune ResponseDaWon Kim, Jin Woong Lee, Piper A Rawding, et al.
Translational Oncology|August 3, 2013
Dasatinib Inhibits DNA Repair after Radiotherapy Specifically in pSFK-Expressing Tumor Areas in Head and Neck Xenograft TumorsHanneke Stegeman, Paul N Span, Paul F J W Rijken, et al.
Science Signaling|November 9, 2021
RetractionToni M Brand, Mari Iida, Kelsey L Corrigan, et al.
Molecular Cancer|November 7, 2013
Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer linesHanneke Stegeman, Johannes H A M Kaanders, Marieke M G Verheijen, et al.
Iscience|November 16, 2020
Activation of EPHA2-ROBO1 Heterodimer by SLIT2 Attenuates Non-canonical Signaling and Proliferation in Squamous Cell CarcinomasSaumya Srivastava, Ka Ming Pang, Mari Iida, et al.
Cancers|October 2, 2020
Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast CancersAadhya Tiwari, Mari Iida, Corinna Kosnopfel, et al.
Head & Neck|March 20, 2023
Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancerKourtney L Kostecki, Mari Iida, Anne L Wiley, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2013
Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancerAnne M Traynor, Tracey L Weigel, Kurt R Oettel, et al.
International Journal of Molecular Sciences|May 25, 2024
MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast CancerMari Iida, Bridget E Crossman, Kourtney L Kostecki, et al.
Molecular Cancer Therapeutics|April 28, 2017
Cotargeting mTORC and EGFR Signaling as a Therapeutic Strategy in HNSCCAdam D Swick, Prashanth J Prabakaran, Margot C Miller, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Advanced Healthcare Materials|April 17, 2025
Dendrimer Conjugates with PD-L1-Binding Peptides Enhance In Vivo Antitumor Immune ResponseDaWon Kim, Jin Woong Lee, Piper A Rawding, et al.
Translational Oncology|August 3, 2013
Dasatinib Inhibits DNA Repair after Radiotherapy Specifically in pSFK-Expressing Tumor Areas in Head and Neck Xenograft TumorsHanneke Stegeman, Paul N Span, Paul F J W Rijken, et al.
Science Signaling|November 9, 2021
RetractionToni M Brand, Mari Iida, Kelsey L Corrigan, et al.
Molecular Cancer|November 7, 2013
Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer linesHanneke Stegeman, Johannes H A M Kaanders, Marieke M G Verheijen, et al.
Iscience|November 16, 2020
Activation of EPHA2-ROBO1 Heterodimer by SLIT2 Attenuates Non-canonical Signaling and Proliferation in Squamous Cell CarcinomasSaumya Srivastava, Ka Ming Pang, Mari Iida, et al.
Cancers|October 2, 2020
Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast CancersAadhya Tiwari, Mari Iida, Corinna Kosnopfel, et al.
Head & Neck|March 20, 2023
Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancerKourtney L Kostecki, Mari Iida, Anne L Wiley, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2013
Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancerAnne M Traynor, Tracey L Weigel, Kurt R Oettel, et al.
International Journal of Molecular Sciences|May 25, 2024
MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast CancerMari Iida, Bridget E Crossman, Kourtney L Kostecki, et al.
Molecular Cancer Therapeutics|April 28, 2017
Cotargeting mTORC and EGFR Signaling as a Therapeutic Strategy in HNSCCAdam D Swick, Prashanth J Prabakaran, Margot C Miller, et al.
Pageof 6